Asia Pacific: The Asia Pacific region, particularly China, Japan, and South Korea, is also projected to experience substantial growth in the anti-inflammatory therapeutics market. This growth can be attributed to the rising geriatric population, increasing healthcare expenditure, and a growing awareness about the benefits of anti-inflammatory drugs in managing various inflammatory conditions.
Europe: In Europe, countries such as the United Kingdom, Germany, and France are expected to contribute significantly to the growth of the anti-inflammatory therapeutics market. The region has a well-established healthcare infrastructure and a high prevalence of inflammatory diseases, which is driving the demand for advanced anti-inflammatory drugs.